Vor Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Vor Bio (Nasdaq: VOR) to participate in upcoming investor conferences to discuss developments in cell and genome engineering.

CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

23rd Annual Needham Virtual Healthcare Conference
Fireside Chat: Tuesday, April 9, 2024 at 3:45 pm ET
Location: Virtual

Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing Summit
Fireside Chat: Monday, April 29, 2024 at 9:30 am ET
Location: Virtual

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

FAQ

When is Vor Bio participating in the 23rd Annual Needham Virtual Healthcare Conference?

Vor Bio is participating in the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 3:45 pm ET.

Where will the Fireside Chat for the Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing Summit take place?

The Fireside Chat for the Chardan's 8th Annual Genetic Medicines + Cell Therapy Manufacturing Summit will take place on Monday, April 29, 2024, at 9:30 am ET.